Vaxart, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $33.6M | $221.2M | $143.7M |
| FY2022 | $43.3M | $153.8M | $44.0M |
| FY2023 | $34.0M | $91.8M | $34.8M |
| FY2024 | $107.5M | $166.4M | $25.2M |
| FY2025 | $98.3M | $186.1M | $53.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $33.6M | $221.2M | $143.7M |
| FY2022 | $43.3M | $153.8M | $44.0M |
| FY2023 | $34.0M | $91.8M | $34.8M |
| FY2024 | $107.5M | $166.4M | $25.2M |
| FY2025 | $98.3M | $186.1M | $53.8M |